In PBMCs of COVID-19 recovered, the percentage of IL2 and IFN-γ secreting CD4+ T cells was enhanced by 64 % and 56 % if activated with epitope mix [Fig. 5 A& B; Table 2 A; Suppl Fig 3 B (d&e)]. The gene discussed is CD4; the disease is COVID-19.